140 related articles for article (PubMed ID: 29477495)
1. Gene Editing of Human Embryos with CRISPR/Cas9: Great Promise Coupled with Important Caveats.
Schenkwein D; Ylä-Herttuala S
Mol Ther; 2018 Mar; 26(3):659-660. PubMed ID: 29477495
[No Abstract] [Full Text] [Related]
2. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
[TBL] [Abstract][Full Text] [Related]
3. CRISPR: Established Editor of Human Embryos?
Li XJ; Tu Z; Yang W; Li S
Cell Stem Cell; 2017 Sep; 21(3):295-296. PubMed ID: 28886363
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
[TBL] [Abstract][Full Text] [Related]
5. [Research advances on the development and application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein system].
Tan JJ; Peng YZ; Huang GT
Zhonghua Shao Shang Za Zhi; 2021 Jul; 37(7):681-687. PubMed ID: 34304411
[TBL] [Abstract][Full Text] [Related]
6. Challenges and advances of CRISPR-Cas9 genome editing in therapeutics.
Stellos K; Musunuru K
Cardiovasc Res; 2019 Feb; 115(2):e12-e14. PubMed ID: 30668679
[No Abstract] [Full Text] [Related]
7. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
Lareau CA; Clement K; Hsu JY; Pattanayak V; Joung JK; Aryee MJ; Pinello L
Nat Methods; 2018 Apr; 15(4):238-239. PubMed ID: 29600992
[No Abstract] [Full Text] [Related]
8. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
Kim ST; Park J; Kim D; Kim K; Bae S; Schlesner M; Kim JS
Nat Methods; 2018 Apr; 15(4):239-240. PubMed ID: 29600990
[No Abstract] [Full Text] [Related]
9. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
Wilson CJ; Fennell T; Bothmer A; Maeder ML; Reyon D; Cotta-Ramusino C; Fernandez CA; Marco E; Barrera LA; Jayaram H; Albright CF; Cox GF; Church GM; Myer VE
Nat Methods; 2018 Apr; 15(4):236-237. PubMed ID: 29600989
[No Abstract] [Full Text] [Related]
10. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
Lescarbeau RM; Murray B; Barnes TM; Bermingham N
Nat Methods; 2018 Apr; 15(4):237. PubMed ID: 29600988
[No Abstract] [Full Text] [Related]
11. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
Nutter LMJ; Heaney JD; Lloyd KCK; Murray SA; Seavitt JR; Skarnes WC; Teboul L; Brown SDM; Moore M
Nat Methods; 2018 Apr; 15(4):235-236. PubMed ID: 29600991
[No Abstract] [Full Text] [Related]
12. CRISPR/Cas System: Recent Advances and Future Prospects for Genome Editing.
Manghwar H; Lindsey K; Zhang X; Jin S
Trends Plant Sci; 2019 Dec; 24(12):1102-1125. PubMed ID: 31727474
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
[TBL] [Abstract][Full Text] [Related]
14. [CRISPR-Cas9 mediated genome editing in Caenorhabditis elegans].
Meng X; Zhou H; Xu S
Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1693-1699. PubMed ID: 29082717
[TBL] [Abstract][Full Text] [Related]
15. Strategies for Optimization of the Clustered Regularly Interspaced Short Palindromic Repeat-Based Genome Editing System for Enhanced Editing Specificity.
Wang YM; Wang HZ; Jian YZ; Luo ZT; Shao HW; Zhang WF
Hum Gene Ther; 2022 Apr; 33(7-8):358-370. PubMed ID: 34963339
[TBL] [Abstract][Full Text] [Related]
16. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
Ahmed MZ; Badani P; Reddy R; Mishra G
J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
[TBL] [Abstract][Full Text] [Related]
17. Virus-Based CRISPR/Cas9 Genome Editing in Plants.
Liu H; Zhang B
Trends Genet; 2020 Nov; 36(11):810-813. PubMed ID: 32828551
[TBL] [Abstract][Full Text] [Related]
18. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
19. [Crispr-Cas9 Gene Editing Revolution and the Its Ethical and Legal Challenges].
Bellver Capella V
Cuad Bioet; 2016; 27(90):223-39. PubMed ID: 27637196
[TBL] [Abstract][Full Text] [Related]
20. [Research progress of CRISPR-Cas9 system for gene therapy].
Zhan C; Xia X
Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):861-869. PubMed ID: 29019208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]